SOW
ALBO

State of Wyoming’s Albireo Pharma Inc ALBO Stock Holding History

State of Wyoming’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7
Closed – – 2228
2022
Q1 		$0 Sell
7
-15
-68% -$439 ﹤0.01% 2099
2021
Q4 		$1K Sell
22
-2
-8% -$53 ﹤0.01% 1842
2021
Q3 		$1K Sell
24
-11
-31% -$340 ﹤0.01% 1202
2021
Q2 		$1K Buy
+35
New +$1.14K ﹤0.01% 1161

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

State of Wyoming's ALBO Position: Q2 2022 in Review

State of Wyoming sold out of Albireo Pharma Inc (ALBO) in Q2 2022, closing a stake of 7 shares.

State of Wyoming first reported a position in ALBO in Q2 2021 and held it in 4 quarters. The position peaked at $1K in Q4 2021. 103 funds tracked by Wall St. Rank hold ALBO as of Q2 2022.

  • State of Wyoming reported no remaining Albireo Pharma Inc position as of Q2 2022 after selling out during the quarter.
  • State of Wyoming sold 7 Albireo Pharma Inc shares in Q2 2022.
  • State of Wyoming first reported a position in Albireo Pharma Inc in Q2 2021 and held it in 4 quarters.
  • State of Wyoming's Albireo Pharma Inc position peaked at $1K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2022.

Based on State of Wyoming's 13F filing for Q2 2022, filed 15 Aug 2022.